{
    "2020-05-06": [
        [
            {
                "time": "",
                "original_text": "华东医药：清理淘汰一批低壁垒、低商业价值的仿制药，厄洛替尼片、伊马替尼片、波舒替尼片。",
                "features": {
                    "keywords": [
                        "华东医药",
                        "清理淘汰",
                        "低壁垒",
                        "低商业价值",
                        "仿制药",
                        "厄洛替尼片",
                        "伊马替尼片",
                        "波舒替尼片"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "政策倒逼淘汰赛加快，多家药企叫停仿制药开发。",
                "features": {
                    "keywords": [
                        "政策",
                        "倒逼",
                        "淘汰赛",
                        "仿制药",
                        "药企"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            }
        ]
    ]
}